The Cystic Fibrosis Foundation is requesting letters of intent for research projects that aim to use available clinical trials in organ transplantation specimens and/or clinical data to improve knowledge of chronic lung allograft dysfunction pathogenesis and explore new approaches to detection, prevention, monitoring, or treatment of chronic lung allograft dysfunction.
Site Search
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. Join the team that’s adding tomorrows.
Learn more about our Board and Officer Conflict of Interest Policy.
Learn more about the Cystic Fibrosis Foundation’s Code of Ethics.
The Kontos Award, created in 2014, recognizes the contributions of nonphysician members of a care team who demonstrate a passion for excellence and commitment to care of individuals with cystic fibrosis.
The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of gastrointestinal manifestations in cystic fibrosis as well as to identify potential novel therapeutic strategies to manage and treat them.
The Cystic Fibrosis Foundation accepts donations from biotechnology and pharmaceutical companies in the form of unrestricted contributions and corporate sponsorships for fundraising events. The Foundation may also receive revenue from Industry companies pursuant to contractual terms for arm’s length transactions.
Clinical postdoctoral research fellowships are offered to support postdoctoral research training related to cystic fibrosis. These awards are intended to enable training in new research areas and methods to advance the scientific knowledge of the applicant and to collect data to enable their transition into an impactful research career.
As a highly committed National Corporate Champion — Daugherty employees have been involved for nearly 15 years and have raised more than $275,000 to help advance the Foundation’s mission. Their steadfast support continues to fuel some of the most innovative CF research in the world.